Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease

Cell Metabolism

Volumn 23, Issue 6, 2016, Pages 1207-1215

  Schafer, Marissa J ^a   Atkinson, Elizabeth J ^a   Vanderboom, Patrick M ^a   Kotajarvi, Brian ^a   White, Thomas A ^a   Moore, Matthew M ^a   Bruce, Charles J ^a   Greason, Kevin L ^a   Suri, Rakesh M ^a   Khosla, Sundeep ^a   Miller, Jordan D ^a   Bergen, H Robert ^a   LeBrasseur, Nathan K ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GROWTH DIFFERENTIATION FACTOR; GROWTH DIFFERENTIATION FACTOR 11; MYOSTATIN; UNCLASSIFIED DRUG; BONE MORPHOGENETIC PROTEIN; GDF11 PROTEIN, HUMAN; MSTN PROTEIN, HUMAN;

AGED; AGING; AMINO ACID SEQUENCE; AORTA STENOSIS; ARTICLE; BRADYCARDIA; CARDIOVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DEMENTIA; DETERIORATION; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; FUNCTIONAL STATUS; HEART ARRHYTHMIA; HEART INFARCTION; HEART VALVE REPLACEMENT; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPOTENSION; KIDNEY FAILURE; LIQUID CHROMATOGRAPHY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MORBIDITY; PLEURA EFFUSION; PNEUMONIA; PRIORITY JOURNAL; SEIZURE; SURGICAL RISK; TACHYCARDIA; URINARY TRACT INFECTION; VERY ELDERLY; ADULT; BLOOD; CHEMISTRY; DEMOGRAPHY; METABOLISM; MIDDLE AGED; MORTALITY; RISK FACTOR; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; AGING; AMINO ACID SEQUENCE; BIOMARKERS; BONE MORPHOGENETIC PROTEINS; CARDIOVASCULAR DISEASES; CHROMATOGRAPHY, LIQUID; DEMOGRAPHY; FEMALE; GROWTH DIFFERENTIATION FACTORS; HUMANS; MALE; MIDDLE AGED; MYOSTATIN; RISK FACTORS; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 84975483043     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2016.05.023     Document Type: Article

References (35)

1. H.R. Bergen 3rd, J.N. Farr, P.M. Vanderboom, E.J. Atkinson, T.A. White, R.J. Singh, S. Khosla, and N.K. LeBrasseur Myostatin as a mediator of sarcopenia versus homeostatic regulator of muscle mass: insights using a new mass spectrometry-based assay Skelet. Muscle 5 2015 21
2. T.N. Burks, and R.D. Cohn Role of TGF-β signaling in inherited and acquired myopathies Skelet. Muscle 1 2011 19
3. J.N. Cash, C.A. Rejon, A.C. McPherron, D.J. Bernard, and T.B. Thompson The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding EMBO J. 28 2009 2662 2676
4. J.N. Cash, E.B. Angerman, C. Kattamuri, K. Nolan, H. Zhao, Y. Sidis, H.T. Keutmann, and T.B. Thompson Structure of myostatin·follistatin-like 3: N-terminal domains of follistatin-type molecules exhibit alternate modes of binding J. Biol. Chem. 287 2012 1043 1053
5. M.A. Egerman, S.M. Cadena, J.A. Gilbert, A. Meyer, H.N. Nelson, S.E. Swalley, C. Mallozzi, C. Jacobi, L.L. Jennings, I. Clay, and et al. GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration Cell Metab. 22 2015 164 174
6. L.P. Fried, C.M. Tangen, J. Walston, A.B. Newman, C. Hirsch, J. Gottdiener, T. Seeman, R. Tracy, W.J. Kop, G. Burke, M.A. McBurnie Cardiovascular Health Study Collaborative Research Group Frailty in older adults: evidence for a phenotype J. Gerontol. A Biol. Sci. Med. Sci. 56 2001 M146 M156
7. S.M. Grundy, I.J. Benjamin, G.L. Burke, A. Chait, R.H. Eckel, B.V. Howard, W. Mitch, S.C. Smith Jr., and J.R. Sowers Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association Circulation 100 1999 1134 1146
8. S.C. Harper, A. Brack, S. MacDonnell, M. Franti, B.B. Olwin, B.A. Bailey, M.A. Rudnicki, and S.R. Houser Is Growth Differentiation Factor 11 a Realistic Therapeutic for Aging-Dependent Muscle Defects? Circ. Res. 118 2016 1143 1150
9. A.C. Hinken, J.M. Powers, G. Luo, J.A. Holt, A.N. Billin, and A.J. Russell Lack of evidence for GDF11 as a rejuvenator of aged skeletal muscle satellite cells Aging Cell 15 2016 582 584
10. A.N. Hoofnagle, J.R. Whiteaker, S.A. Carr, E. Kuhn, T. Liu, S.A. Massoni, S.N. Thomas, R.R. Townsend, L.J. Zimmerman, E. Boja, and et al. Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based Assays Clin. Chem. 62 2016 48 69
11. L. Katsimpardi, N.K. Litterman, P.A. Schein, C.M. Miller, F.S. Loffredo, G.R. Wojtkiewicz, J.W. Chen, R.T. Lee, A.J. Wagers, and L.L. Rubin Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors Science 344 2014 630 634
12. N.K. Lebrasseur, S.J. Achenbach, L.J. Melton 3rd, S. Amin, and S. Khosla Skeletal muscle mass is associated with bone geometry and microstructure and serum insulin-like growth factor binding protein-2 levels in adult women and men J. Bone Miner. Res. 27 2012 2159 2169
13. F.S. Loffredo, M.L. Steinhauser, S.M. Jay, J. Gannon, J.R. Pancoast, P. Yalamanchi, M. Sinha, C. Dall'Osso, D. Khong, J.L. Shadrach, and et al. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy Cell 153 2013 828 839
14. M.A. Makary, D.L. Segev, P.J. Pronovost, D. Syin, K. Bandeen-Roche, P. Patel, R. Takenaga, L. Devgan, C.G. Holzmueller, J. Tian, and L.P. Fried Frailty as a predictor of surgical outcomes in older patients J. Am. Coll. Surg. 210 2010 901 908
15. E.M. McNally Questions and Answers About Myostatin, GDF11, and the Aging Heart Circ. Res. 118 2016 6 8
16. A.C. McPherron Metabolic Functions of Myostatin and Gdf11 Immunol. Endocr. Metab. Agents Med. Chem. 10 2010 217 231
17. A.C. McPherron, A.M. Lawler, and S.J. Lee Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member Nature 387 1997 83 90
18. A.C. McPherron, A.M. Lawler, and S.J. Lee Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11 Nat. Genet. 22 1999 260 264
19. M. Nakashima, T. Toyono, A. Akamine, and A. Joyner Expression of growth/differentiation factor 11, a new member of the BMP/TGFbeta superfamily during mouse embryogenesis Mech. Dev. 80 1999 185 189
20. New York Heart Association M.I. Ferrer Nomenclature and criteria for diagnosis of diseases of the heart and great vessels 9th edn 1994 Little, Brown & Co. Boston
21. K.A. Olson, A.L. Beatty, B. Heidecker, M.C. Regan, E.N. Brody, T. Foreman, S. Kato, R.E. Mehler, B.S. Singer, K. Hveem, and et al. Association of growth differentiation factor 11/8, putative anti-ageing factor, with cardiovascular outcomes and overall mortality in humans: analysis of the Heart and Soul and HUNT3 cohorts Eur. Heart J. 36 2015 3426 3434
22. R.L. Osnabrugge, D. Mylotte, S.J. Head, N.M. Van Mieghem, V.T. Nkomo, C.M. LeReun, A.J. Bogers, N. Piazza, and A.P. Kappetein Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study J. Am. Coll. Cardiol. 62 2013 1002 1012
23. A.K. Padyana, B. Vaidialingam, D.B. Hayes, P. Gupta, M. Franti, and N.A. Farrow Crystal structure of human GDF11 Acta Crystallogr. F Struct. Biol. Commun. 72 2016 160 164
24. E. Pardali, and P. Ten Dijke TGFβ signaling and cardiovascular diseases Int. J. Biol. Sci. 8 2012 195 213
25. T. Poggioli, A. Vujic, P. Yang, C. Macias-Trevino, A. Uygur, F.S. Loffredo, J.R. Pancoast, M. Cho, J. Goldstein, R.M. Tandias, and et al. Circulating Growth Differentiation Factor 11/8 Levels Decline With Age Circ. Res. 118 2016 29 37
26. J.D. Puskas, P.D. Kilgo, V.H. Thourani, O.M. Lattouf, E. Chen, J.D. Vega, W. Cooper, R.A. Guyton, and M. Halkos The society of thoracic surgeons 30-day predicted risk of mortality score also predicts long-term survival Ann. Thorac. Surg. 93 2012 26 33 discussion 33-35
27. B.L. Riggs, L.J. Melton 3rd, R.A. Robb, J.J. Camp, E.J. Atkinson, J.M. Peterson, P.A. Rouleau, C.H. McCollough, M.L. Bouxsein, and S. Khosla Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites J. Bone Miner. Res. 19 2004 1945 1954
28. B.D. Rodgers, and J.A. Eldridge Reduced Circulating GDF11 Is Unlikely Responsible for Age-Dependent Changes in Mouse Heart, Muscle, and Brain Endocrinology 156 2015 3885 3888
29. R. Rowe, J. Iqbal, R. Murali-Krishnan, A. Sultan, R. Orme, N. Briffa, M. Denvir, and J. Gunn Role of frailty assessment in patients undergoing cardiac interventions Open Heart 1 2014 e000033
30. C.M. Shuford, R.R. Sederoff, V.L. Chiang, and D.C. Muddiman Peptide production and decay rates affect the quantitative accuracy of protein cleavage isotope dilution mass spectrometry (PC-IDMS) Mol. Cell. Proteomics 11 2012 814 823
31. M. Sinha, Y.C. Jang, J. Oh, D. Khong, E.Y. Wu, R. Manohar, C. Miller, S.G. Regalado, F.S. Loffredo, J.R. Pancoast, and et al. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle Science 344 2014 649 652
32. S.C. Smith, X. Zhang, X. Zhang, P. Gross, T. Starosta, S. Mohsin, M. Franti, P. Gupta, D. Hayes, M. Myzithras, and et al. GDF11 does not rescue aging-related pathological hypertrophy Circ. Res. 117 2015 926 932
33. V.H. Thourani, R.M. Suri, R.L. Gunter, S. Sheng, S.M. O'Brien, G. Ailawadi, W.Y. Szeto, T.M. Dewey, R.A. Guyton, J.E. Bavaria, and et al. Contemporary real-world outcomes of surgical aortic valve replacement in 141,905 low-risk, intermediate-risk, and high-risk patients Ann. Thorac. Surg. 99 2015 55 61
34. R.G. Walker, T. Poggioli, L. Katsimpardi, S.M. Buchanan, J. Oh, S. Wattrus, B. Heidecker, Y.W. Fong, L.L. Rubin, P. Ganz, and et al. Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation Circ. Res. 118 2016 1125 1142
35. T.A. White, and N.K. LeBrasseur Myostatin and sarcopenia: opportunities and challenges - a mini-review Gerontology 60 2014 289 293